OPPENHEIMER ASSET MANAGEMENT INC.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1269119
NEW YORK, NY
Position in CRNX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$812,874
+$23,641 QoQ
Shares Held
21,723
-0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#133
of 264 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER ASSET MANAGEMENT INC. holds $60,234,083 across 32 Biotechnology names. CRNX ranks #15 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
447,426 | $12,290,791 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
35,781 | $10,196,511 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,931 | $8,906,863 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,608 | $5,902,596 | |
| 5 | TECH |
BIO-TECHNE Corp
|
39,080 | $2,760,999 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
29,098 | $2,277,499 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
8,356 | $2,013,545 | |
| 8 | INSM |
INSMED Inc
|
16,061 | $1,712,423 |
All Filings in CRNX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $812,874 | 21,723 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $789,233 | 21,730 | Shares | Other | 2026-04-24 | |
| 2025-12-31 | $827,937 | 17,786 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $220,619 | 5,297 | Shares | Other | 2025-11-06 | |
| 2024-12-31 | $257,592 | 5,038 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $215,437 | 4,216 | Shares | Other | 2024-11-05 | |
| 2024-03-31 | $200,159 | 4,276 | Shares | Other | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||